Beruflich Dokumente
Kultur Dokumente
the aorta starts at the aortic valve and ends at the iliac bifucation. Asc. Arch, desc. Intima , media and adventitia
TYPES:
True aneurysms: if contain all the three layers. False/pseudoaneurysm: if only the outer layer remains. Based on location: Acc. to shape: Fusiform (symmetrical) Saccular (asymmetrical)
Abdominal aortic aneurysms(AAA): 75%, infrarenal most common Thoracic aortic aneurysm: 25%, ( asc., arch, desc.) Thoracoabdominal aortic aneurysm (TAAA):
TAA
Diameter of the thoracic aorta 1.5 times greater than normal (or larger) Incidence 5.9 per 100,000 personyears Median age 65 years (2-4)M>F Desc. TAA> Asc.TAA> Aortic arch
TAA
DEGENERATION & DISSECTION Atherosclerosis(80%) Chronic aortic dissection(17%) Marfans syndrome, Loeys Dietz syndrome Ehlers-danlos syndrome Familial thoracic aortic aneurysm syndrome Congential aortic aneurysms (Bicuspid aortic valve,
coarctation)
Traumatic aneurysms Annuloaortic ectasia: isolated
dilation of asc aorta, aortic root, Syphilitic (rare) aortic valve annulus Central AR Tuberculosis aneurysms Mycotic aneurysm Vasculitides : takayasus arteritis, giant cell arteritis Spondyloarthopathies: Bechets ds causes TAAA
Aortic dissection
Ascending (65%), arch (20%), descending thoracic (10%), abdominal (5%) Acute (2/3), chronic (1/3)
STANFORD CLASSIFICATION
Type A: involve ascending aorta Type B: dont involve ascending aorta
DEBAKEY CLASSIFICATION
CLINICAL FEATURES
Remain asymptomatic for long(silent killer) Chest or back pain Rupture of asc. Aortic Hoarseness Atelectasis Dysphagia Dyspnea Superior vena cava syndrome Wheezing, cough, hematemesis, hemoptysis Symptoms of AR Embolism with stroke,mesentric or limb ischemia
aneurysm in to pericardial sac causes cardiac temponade Desc. AA rupture causes hemothorax, aortobronchial fistula, aortoesophageal fistula
DIAGNOSIS
Abnormal chest x-ray Transthoracic ultrasound examination Aortic angiography & digital subtraction angiography (gold standard) CT, MRI: 87-100% CTA MRA TEE : 99-100% Abdominal USG
TREATMENT OPTIONS
Marfans or familial thoracic aneurysm diameter Ascending aorta > 5.0cm Descending aorta > 6.0cm
Severe aortic regurgitation Aortoannular ectasia with dilated aortic root Congential bicuspid aortic valve Contained or impending rupture Symptoms refractory to medical management Increase in aneurysm diameter > 1cm/year
REPAIR OPTIONS
Endovascular surgery:
Requires single small incision in the groin area.
An endovascular graft is inserted through the femoral artery via a catheter and deployed inside the lumen, relining the aorta.
Average ICU stay: 2-3 days Average recovery time: 1-2 weeks
REPAIR OPTIONS
Open surgery:
Requires thoracotomy Aorta is cross-clamped above diseased aortic segment Affected segment is replaced with fabric surgical graft Average hospital stay: 2-3 weeks Average recovery time: 3 months Elective repair: up to 10% mortality Emergent repair: up to 50% mortality
1. Urgency of the surgery : emergent, urgent or elective 2. Pathology, anatomic extent of the lesion provide information about physiologic impact and consequences of the lesion, permitting anaesthesiologist to anticipate potential difficulties associated with anaesthetic procedures, problems related to surgical repair and postoperative complications. 3. Baseline functional reserve of each organ system : (often elderly and have CO-EXISTING DISEASES)
Pulmonary disease:
COPD, chronic bronchitis, smoking Increased risk of post-op pulmonary complications PFTs useful in evaluating &optimizing respiratory function Baseline hypercapnia(paCo2>45mmhg) increases the risk Bronchodilators may be indicated but risk of beta agonist induced arrhythmia or MI should be considered. Antibiotics ; short course of glucocorticoids
Renal insufficency:
Alters fluid management Serum creatinine level>2mg/dl creatinine clearance <60ml/min are independent risk factors for cardiac complications Avoid nephrotoxic drugs N-acetylcysteine or sodium bicarbonate to reduce risk of contrast related nephropathy
CNS:
Cerbrovascular disease BP management to ensure adequate cerebral perfusion
4. Hemodynamic status, intravascular volume access and management 5. Airway patency:Aortic pathology distorting trachea/bronchus
may increase difficulty to tracheal and endobronchial intubation.
6.Pre-operative medications: Antihypertensives, beta-blockers, other cardiac medications, pulmonary, antiseizure medication continued till morning of surgery Discontinue oral hypoglycemics(metformin) Warfarin, Coumadin discontinued 3-7 days before Aspirin, clopidrogel 1week Ticlopidine 14 days Add heparin if need anticoagulation
7. Prepare blood/PRC (6-15 units), FFP 10-20 ml/kg, plateletpheresis or platelet concentrate (10-20 units), cryoprecipitate 10-20 units 8. Discuss anesthetic and operative plan with the surgical team to properly prepared for all possible contingencies. 9. Assess risk of pulmonary aspiration 10. Plan for CPB, left heart bypass or circulatory arrest
2. DRUGS :
Cardiovascular drugs
Adrenalin (0.1 mg/ml) = 10 ml for IV bolus Atropine (0.6 mg/ml) norepinephrine : Bolus(0.1ug/kg) ,220ug/min infusion dopamine (1-20ug/kg/min) Nitroprusside (100ug/ml) ; IV infusion(0.5-10ug/kg/min Nitroglycerin (100 ug/ ml) = 100 ml for IV infusion
Esmolol (0.2-0.5mg/kg);50-200ug/kg/min Phenylephrine 50-100ug;0.25-1ug/kg/min
Others :
Diuretics: 25% mannitol 0.25-1 gm/kg Furosemide 40 mg/ml
Antiarrhymic agents: xylocard, cordarone (150 ml/3 ml/amp), MgSO4 (2 gm) Sodium bicarb 50 ml/amp
Anticoagulant:
Heparin 1 mg (100 units)/kg 10% Calcium gluconate/chloride 10 ml/amp without using CPB Antibiotics : Heparin 3 mg (300 units) kg Humulin R and 50% glucose 50 ml x 2 when using CPB
Premedication
Patient should be brought in preoperative ward 1 hr before surgery Secure large bore intravascular access Alleviate fear, anxiety and pain Midazolam 0.01-0.15mg/kg i/v Morphine 0.05-0.1mg/kg i/m or fentanyl 0.5-1ug/kg i/v Continue cardiac medications till morning of surgery Small oral dose of clonidine 2ug/kg reduce incidence of perioperative MI without affecting hemodynamics Catheterize patient and note urinary output
MONITORING:
HEMODYNAMIC MONITORING:
Temperature monitoring:
Upper body core temp. : nasopharyngeal or esophageal Lower body core temp. : bladder, rectal
Others:
Arterial blood gases, electrolytes (Na+, K+, Ca++), Hct Activated clotting time (ACT), (Coagulogram) Blood sugar Urine output Estimated blood loss
Intra-operative management
Position : Discuss with the surgeon
Supine for median sternotomy and endovascular stent repair Right lateral decubitus for left thoracotomy
COMPANY LOGO
Performed without ECC support. Surgical simplicity. Obligatory ischemia to organs distal to clamp Increased incidence of paraplegia and renal failure Cross-clamp time should not exceed 30 minutes Proximal aortic hypertension, bleeding from arterial collaterals, hemodynamic instability upon reperfusion COMPANY LOGO
Increased arterial blood pressure above the clamp Decreased arterial blood pressure below the clamp Clamping of the increases : mean arterial pressure by 35%
Central venous pressure by 56% Mean pulmonary arterial pr by 43% Pulmonary capillary wedge pr by 90%
HR & LV stroke work do not changed significantly LV wall tension Ejection fraction coronary blood flow
AT SUPRACELIAC AORTIC CROSS-CLAMPING: MAP increase by 54% PCWP by 38% EF decreases by 38% Significant wall motion abnormalities AT SUPRARENAL LEVEL: similar but smaller CVS changes AT INFRARENAL LEVEL: minimal cnanges with no wall motion abnormalities
Metabolic changes
Total body 02 consumption Total body CO2 production Respiratory alkalosis mixed venous O2 saturation Metabolic acidosis total body O2 extraction epinephrine & norepinephrine Tissue perfusion distal to cross clamp depends on proximal aortic pressure & independent of CO. Renal blood flow markedly decrease ( 83-90%) during thoracic aortic cross clamping Increased plasma renin activity, other mediators like plasma endothelin, myoglobin, PGs contribute to decreased renal perfusion
Therapeutic interventions
Afterload reduction
Sodium nitroprusside Inhaled anaesthetics Amrinone Shunts and aortofemoral bypass
Preload reduction
Nitroglycerin Controlled phlebotomy Atrial to femoral bypass
Renal protection
Fluid administration Distal aortic perfusion techniques Selective renal artery perfusion Mannitol and drugs to augment renal perfusion
METABOLIC:
Inc total body O2 consumption Decrease mixed venous O2 saturation Metabolic acidosis
Therapeutic intervention: inhaled anaesthetic vasodilators fluid administration vasoconstrictors Sodium bicarbonate Reapply clamp for severe hypotension
Aortic unclamping
Tapered heparin coated tube so that both ends can serve as arterial cannulas Proximal cannulation sites: ascending aorta or aortic arch Distal cannulation sites: distal descending thoracic aorta, iliac artery or femoral artery Passive shunting of blood from proximal to distal aorta Simple, inexpensive, requires only partial or no anticoagulation
COMPANY LOGO
COMPANY LOGO
COMPANY LOGO
COMPANY LOGO
To Maintain hemodynamic stability during induction, intubation and maintenance of anesthesia with cardiac, vasoactive and fluid management To prevent rupture of aneurysm(during induction) Gentle laryngoscopy and endotracheal / endobronchial intubation Avoid hypo or hyperthermia
Anaesthetic technique:
Induction
Slow & controlled PREOXYGENATION No single best anaesthetic technique Intravenous induction agents: etomidate, propofol, thiopental or ketamine(severe hypotension) Combination with fentanyl(3-5ug/kg) and midazolam 1-2mg IV or low dose volatile anaesthetic
Intubation:
Consider emergent and urgent patient as full stomach. Rapid sequence induction and intubation should be performed Succinylcholine or short-acting NDP (cis-atracurium can be used
Combination of O2, N2O, potent opoids(fentanyl, sufentanil), Low dose potent volatile agents(isoflurane, sevoflurane,desflurane. Muscle relaxant: preferred
Vecuronium,0.08-0.12 mg/kg Rocuronium,0.45-0.9mg/kg Cisatracurium0.1-0.15 mg/kg
TIVA may be optimal if transcranial MEP monitoring is used Nitroprusside (0.5-2ug/kg/min )and esmolol (25300ug/kg/min) infusion EXTUBATION should always take place in the ICU & only after a significant period of hemodynamic & metabolic stability
Throacoabdominal aortic aneurysm extent Hypotension or cadiogenic shock Emergency operation Aortic rupture Presence of aortic dissection Duration of aortic cross clamp Surgical technique used for repair Prior aortic aneurysm repair Occulsive peripheral vascular disease
MINIMIZE AORTIC CROSS-CLAMP TIME Distal aortic perfusion Passive shunt Partial left heart bypass Partial cardiopulmonary bypass INCREASE SPINAL CORD PERFUSION PRESSURE Re-implantation of critical intercostal & segmental arterial branches Lumbar CSF drainage Arterial pressure augmentation (MAP> 85mmhg)
SCPP= distal MAP CSF pressure or CVP Silicon catheter at L3 & L4 interspace
ARTERIAL PRESSURE AUGMENTATION Maintain MAP in range of 80-100mmhg Spnal cord perfusion pressure above 70mmhg Decreasing lumbar CSF pressure alone may have negligible effect if MAP is insufficient
Deliberate hypothermia
SSEPs: dec in amplitude &latency of SSEP > 1430minutes increases risk of neurologic deficit
MEPs
Post-operative neurologic assessment for early detection of delayed onset paraplegia by serial neurologic examinations
Antifibrinolytic therapy:
E aminocaproic acid 5-10gm f/by 1gm/hr; tranexamic acid 10mg/kg f/by 1mg/kg/hr Desmopressin : to increase level of von-willibrand factor& factorVIII Recombinant activated factor VIIa 90ug/kg i/v; repeated after 2 hours
Complete rewarming
Arterial blood gases and electrolytes should be measured frequently. Sodium bicarbonate to correct severe metabolic acidosis(pH<7.20): 1-3meq/kg/hr Calcium chloride may be necessary following massive tranfusion of citrated blood products Hyperkalemia should be treated aggressively esp. in oliguric or anuric patients
Post-operative analgesia
Thoracotomy & TAAA incision very painful, cause respiratory splinting, retention of airway secretions post-operative respirtory failure Epidural analgesia is effective means of providing intra-op &post-op analgesia Epidural analgesia regimen should be formulated to minimise interference with ability to monitor lower extremity neurologic function and not cause sympathetic blockade Bupivicaine 0.05% combined with fentanyl 2ug/ml via PCEA infusion @ 4-8ml/hr Bolus administration should be avoided. Epidural catheter can be inserted prior to, at the time of surgery, or in the post-operative period Coagulation parameteres should be satisfactory prior to insertion and during removal of catheter
Thankyou
THE SITUATION
AAAs are the tenth leading cause of death in men over 50.
An estimated 1 million men and women worldwide are living with undiagnosed AAAs.
AAA
Diameter > 3cm Atherosclerosis & aging Infrarenal arota: no vasa vasorum
Prevalence: 10% in men, 3% in women Perioperative mortality with elective repair: 2-5% Emergency repair : 50% When AAAs rupture, only 18% of patients survive.
Size of AAA directly related to morbidity and risk of rupture >5cm diameter - incidence of rupture substantially 1 year incidence of probable rupture- 35% for aneurysm > 7cm Mural thrombosis are common
SYMPTOMS
Asymptomatc Palpable, pulsatile ,non-tender mass on routine exam/ incidental finding during imaging of abdomen Pain or tenderness in the lower back, abdomen Indications of rupture may include: Lightheadedness Sweating Clammy skin Nausea/vomitting Shock palpable/ pulsatile abdominal mass; hypotension (<1/3 cases)
DIAGNOSIS
Physical examination of abdomen
Pulsatile, palpable abdominal mass Stiff /rigid abdomen Bruit over the aorta
Abdominal ultrasound , may detect mural thrombosis As required: MRI, CT or other imaging systems Angiography rarely done CTA
Abdominal radiography :
TREATMENT OPTIONS
Medical management/monitoring(watchful waiting) :AAAs <5.5cm Open surgery: AAAs exceeds 5.5cm Endovascular repair
No proven lifestyle changes can decrease the size of TAAs.
TEVAR animation video